Phase 1 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed (confirmed by a lab test) with a specific type of cancer in or near the digestive system, such as pancreatic cancer, stomach/esophagus cancer, bile duct cancer, gallbladder cancer, or a related type, that has spread locally or to other parts of the body
- If you previously had yellowing of the skin or eyes caused by your tumor blocking a bile duct, that condition must now be mostly resolved and you must have a metal stent (a small tube) in place to keep the duct open
- You are 18 years of age or older
- You are reasonably active and able to care for yourself day-to-day (confirm with trial site)
- Your doctor expects you to live for more than 3 months
- Your blood counts, liver function, and kidney function are within acceptable ranges as measured by blood tests (confirm specific values with trial site)
- Your cancer can be measured on scans, or may not need to be measurable at all
- If you are a woman who could become pregnant, or a sexually active man, you must be willing to use effective birth control during treatment and for 3 months afterward
- If you are a woman who could become pregnant, you must have a negative pregnancy test before starting the trial
- If you are taking certain medications that interact with a drug called irinotecan, you should be willing to switch to alternatives where possible (confirm with trial site)
Who may not be able to join:
- You have had radiation therapy for any cancer in the past
- You have already had chemotherapy specifically for cancer that has spread to other parts of the body (though you may still be eligible if your cancer came back within 6 months of surgery-related chemotherapy — confirm with trial site)
- You have an inflammatory bowel condition such as Crohn's disease or ulcerative colitis
- You are currently experiencing diarrhea (note: pancreatic cancer patients with digestion problems must be taking enzyme replacement therapy to be considered)
- You have moderate or severe nerve damage or nerve pain (such as numbness or tingling)
- Cancer has spread to your brain
- You have serious ongoing medical or mental health conditions that your doctor feels would make treatment too risky
- You have active, uncontrolled bleeding
- You are currently pregnant or breastfeeding
- You have had major surgery within the past 4 weeks
- You have had another type of cancer, unless it was an early-stage skin cancer or cervical cancer, or a previously treated cancer where the chance of it coming back is considered low (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel Catenacci, MD, University of Chicago Medicine
Phone: 773-702-7596
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The maximum dose tolerated
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.